Trevi Therapeutics (TRVI) has an average rating of buy and mean price target of $27.33, according to analysts polled by FactSet.
What else is happening in Research?
Research
Morgan Stanley Downgrades NNN REIT to Equal Weight From Overweight, $50 Price Target
NNN REIT (NNN) has an average rating of hold and mean price target of $45.63 according to analysts polled by FactSet.Price: $48.84, Change: $-0.75, Percent Change: -1.51%
$NNN
Research
Needham Downgrades Personalis to Hold From Buy
Personalis (PSNL) has an average rating of Buy and mean price target of $12.40, according to analysts polled by FactSet.Price: $13.21, Change: $-2.18, Percent Change: -14.17%
$PSNL
Research
DNB Carnegie Upgrades Saab to Buy, Boosts PT
DNB Carnegie on Monday upgraded Swedish defense and security group Saab (SAAB-B.ST) to buy from hold and raised the price target to 630.00 kronor from 550.00 kronor.
$SAAB-B.ST